Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Barth

Showing results (631-640 of 652) with videos related to

Pageof 66
Sort By:
Cancer Medicine|March 17, 2022
Evaluation of autoantibodies as predictors of treatment response and immune-related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan-cancer studyDominik A Barth, Stefanie Stanzer, Jasmin Spiegelberg, et al.
Orphanet Journal of Rare Diseases|April 29, 2018
Migalastat improves diarrhea in patients with Fabry disease: clinical-biomarker correlations from the phase 3 FACETS trialRaphael Schiffmann, Daniel G Bichet, Ana Jovanovic, et al.
Urologic Oncology|July 12, 2021
Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-upDominik A Barth, Nazanin Sareban, Andrea K Lindner, et al.
Science (New York, N.Y.)|March 26, 1999
Hydrogen peroxide on the surface of EuropaR W Carlson, M S Anderson, R E Johnson, et al.
Frontiers in Pediatrics|April 23, 2025
Risk scores for choledocholithiasis perform poorly in patients with hemolytic diseases: a PEDI database reportJennifer Thompson, Wenly Ruan, Douglas S Fishman, et al.
Cancers|August 23, 2020
C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center StudyJakob M Riedl, Dominik A Barth, Wolfgang M Brueckl, et al.
Thrombosis and Haemostasis|July 13, 2021
Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-PaclitaxelJakob M Riedl, Esther Schwarzenbacher, Florian Moik, et al.
Frontiers in Immunology|April 18, 2022
Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer StudyDominik A Barth, Stefanie Stanzer, Jasmin A Spiegelberg, et al.
Science (New York, N.Y.)|September 27, 1991
Galileo ultraviolet spectrometer experiment: initial venus and interplanetary cruise resultsC W Hord, C A Barth, L W Esposito, et al.
Scientific Reports|June 2, 2017
Persistent spatial structuring of coastal ocean acidification in the California Current SystemF Chan, J A Barth, C A Blanchette, et al.
Pageof 66

Showing results (631-640 of 652) with videos related to

Sort By:
Pageof 66
Cancer Medicine|March 17, 2022
Evaluation of autoantibodies as predictors of treatment response and immune-related adverse events during the treatment with immune checkpoint inhibitors: A prospective longitudinal pan-cancer studyDominik A Barth, Stefanie Stanzer, Jasmin Spiegelberg, et al.
Orphanet Journal of Rare Diseases|April 29, 2018
Migalastat improves diarrhea in patients with Fabry disease: clinical-biomarker correlations from the phase 3 FACETS trialRaphael Schiffmann, Daniel G Bichet, Ana Jovanovic, et al.
Urologic Oncology|July 12, 2021
Prognostic relevance of ABO blood group system in non-metastatic renal cell carcinoma: An analysis of two independent European cohorts with long-term follow-upDominik A Barth, Nazanin Sareban, Andrea K Lindner, et al.
Science (New York, N.Y.)|March 26, 1999
Hydrogen peroxide on the surface of EuropaR W Carlson, M S Anderson, R E Johnson, et al.
Frontiers in Pediatrics|April 23, 2025
Risk scores for choledocholithiasis perform poorly in patients with hemolytic diseases: a PEDI database reportJennifer Thompson, Wenly Ruan, Douglas S Fishman, et al.
Cancers|August 23, 2020
C-Reactive Protein (CRP) Levels in Immune Checkpoint Inhibitor Response and Progression in Advanced Non-Small Cell Lung Cancer: A Bi-Center StudyJakob M Riedl, Dominik A Barth, Wolfgang M Brueckl, et al.
Thrombosis and Haemostasis|July 13, 2021
Patterns of Thromboembolism in Patients with Advanced Pancreatic Cancer Undergoing First-Line Chemotherapy with FOLFIRINOX or Gemcitabine/nab-PaclitaxelJakob M Riedl, Esther Schwarzenbacher, Florian Moik, et al.
Frontiers in Immunology|April 18, 2022
Patterns of Peripheral Blood B-Cell Subtypes Are Associated With Treatment Response in Patients Treated With Immune Checkpoint Inhibitors: A Prospective Longitudinal Pan-Cancer StudyDominik A Barth, Stefanie Stanzer, Jasmin A Spiegelberg, et al.
Science (New York, N.Y.)|September 27, 1991
Galileo ultraviolet spectrometer experiment: initial venus and interplanetary cruise resultsC W Hord, C A Barth, L W Esposito, et al.
Scientific Reports|June 2, 2017
Persistent spatial structuring of coastal ocean acidification in the California Current SystemF Chan, J A Barth, C A Blanchette, et al.
Pageof 66